Physician
Martha Preciado, M.D. INC.
Martha Preciado, M.D. INC. was paid $4.44M by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 28% of everything it billed.
33Billing provider infoMARTHA PRECIADO, M.D. INC.
LOS ANGELES, CA 90033
LOS ANGELES, CA 90033
33aNPI1477694859assigned 02/09/2007
33bProvider typeCardiovascular Disease Physician
28Total paid$4.44M
24GClaims89,743
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in California
Rank by total paid#17 of 714
Median peer was paid$28K
This provider vs. median157×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,710 | $424K | |
| 2019 | 12,970 | $715K | |
| 2020 | 11,461 | $605K | |
| 2021 | 14,385 | $742K | |
| 2022 | 13,981 | $727K | |
| 2023 | 14,964 | $830K | |
| 2024incomplete | 11,272 | $401K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 28% | 10,972 | 10,835 | $1.23M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 10% | 2,373 | 2,353 | $460K |
| 93351 | 8.0% | 2,272 | 2,259 | $356K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.6% | 9,966 | 9,608 | $339K |
| 93000 | 5.8% | 19,691 | 18,532 | $257K | |
| J2785 | Injection, regadenoson, 0.1 mg | 5.0% | 2,334 | 2,319 | $221K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.4% | 6,702 | 6,454 | $194K |
| 93224 | 4.1% | 3,146 | 3,114 | $182K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 3.6% | 2,305 | 2,289 | $158K |
| 93880 | 3.4% | 2,113 | 2,082 | $149K | |
| 94621 | 3.1% | 2,793 | 2,754 | $140K | |
| 93970 | 2.7% | 1,809 | 1,780 | $120K |
18 more codes
| 93325 | 2.3% | 2,658 | $104K | |
| 93320 | 2.3% | 2,596 | $103K | |
| 93925 | 2.0% | 1,908 | $89K | |
| 93922 | 1.7% | 1,934 | $76K | |
| 93015 | 1.7% | 2,479 | $75K | |
| 93356 | 1.0% | 2,618 | $45K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 657 | $44K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 623 | $33K |
| 94010 | <1% | 3,185 | $32K | |
| 94760 | <1% | 2,285 | $16K | |
| 93290 | <1% | 830 | $12K | |
| 93283 | <1% | 141 | $6K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 190 | $5K |
| 93978 | <1% | 27 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 126 | $595.15 |
| 94762 | <1% | 260 | $519.53 | |
| 99072 | <1% | 738 | $348.20 | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 12 | $254.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRECIADO, MARTHA (PRESIDENT)